X
Navigation Menu
Products
Services
Tools
Resources
logo
AAT Bioquest

 
search
logo
AAT Bioquest
Contact us
Company
Telephone:1-408-733-1055
Fax:1-408-733-1304
Hours:Monday to Friday
8:30 - 17:30 PST (GMT-8)
Location:5775 W Las Positas Blvd.
Pleasanton, CA, 94588
USA

Email us
Sales:sales@aatbio.com
Technical Support:support@aatbio.com
Website:websupport@aatbio.com
General Inquiries:info@aatbio.com
Order info
United States of America
Telephone:1-408-733-1055
Fax:1-408-733-1304
Email:sales@aatbio.com
Purchase Order:sales@aatbio.com

International
Click here to see all available distributors
Products
Services
Tools
Resources
 
search
calculatorCalculator

Matrix metalloproteinase-1 Inhibitors (IC50, Ki)

Structure
▲
▼
Compound Name
▲
▼
Standard Type
▲
▼
Standard Values (in nM)
▲
▼
(2R)-N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl-(pyridin-3-ylmethyl)amino]-3-methylbutanamide;hydrochlorideIC5034.3 [1]
(2R)-N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl-(pyridin-3-ylmethyl)amino]-3-methylbutanamide;hydrochlorideKi33.0 [1]
MarimastatIC502.9 [1]
MarimastatKi0.7 [1], 1.0 [2], 1.1 [3]
IlomastatIC503.0 [1]
IlomastatKi2.0 [1]
PrinomastatIC508.2 [1]
PrinomastatKi8.2 [1]
BatimastatIC501.2 [1]
BatimastatKi0.5 [1]
4-[4-(4-Chloro-phenoxy)-benzenesulfonylmethyl]-tetrahydro-pyran-4-carboxylic acid hydroxyamideIC5034.0 [1]
4-[4-(4-Chloro-phenoxy)-benzenesulfonylmethyl]-tetrahydro-pyran-4-carboxylic acid hydroxyamideKi590.0 [1]
n-[3-(n'-Hydroxycarboxamido)-2-(2-methylpropyl)-propanoyl]-o-tyrosine-n-methylamideIC501.9 [1], 3.0 [2], 20.0 [3]
n-[3-(n'-Hydroxycarboxamido)-2-(2-methylpropyl)-propanoyl]-o-tyrosine-n-methylamideKi1.0 [1], 6.0 [2], 10.0 [3]
Methylamino-phenylalanyl-leucyl-hydroxamic acidIC503.0 [1], 25.0 [2], 60.0 [3]
Methylamino-phenylalanyl-leucyl-hydroxamic acidKi6.0 [1], 7.0 [2]
(R)-N1-((S)-3,3-Dimethyl-1-(methylamino)-1-oxobutan-2-yl)-N4-hydroxy-2-isobutylsuccinamideIC503.0 [1], 5.0 [2], 5.01 [3], 10.0 [4]
(R)-N1-((S)-3,3-Dimethyl-1-(methylamino)-1-oxobutan-2-yl)-N4-hydroxy-2-isobutylsuccinamideKi2.0 [1]
N-Hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)acetamideIC502900.0 [1], 12000.0 [2], 50000.0 [3]
CipemastatIC502.3 [1]
CipemastatKi0.3 [1], 3.0 [2], 7000.0 [3]
N-Hydroxy-N~2~-[(4-Methoxyphenyl)sulfonyl]glycinamideIC503000.0 [1]
N-Hydroxy-N~2~-[(4-Methoxyphenyl)sulfonyl]glycinamideKi33.0 [1], 77.0 [2], 200.0 [3]
n-Hydroxy-2-[(4-methoxy-benzenesulfonyl)-pyridin-3-ylmethyl-amino]-3-methyl-benzamideIC50143.0 [1]
2-(Biphenyl-4-ylsulfonamido)-N-hydroxyacetamideIC50610.0 [1], 970.0 [2]
2-(Biphenyl-4-ylsulfonamido)-N-hydroxyacetamideKi365.0 [1]
N-Hydroxy-2-[(4-nitro-benzyl)-pentafluorobenzenesulfonyl-amino]-acetamideIC503.02 [1]
N-Hydroxy-2-[(4-nitro-benzyl)-pentafluorobenzenesulfonyl-amino]-acetamideKi3.0 [1], 5.0 [2]
N-(3-Methoxybenzyl)-4-Oxo-3,4-Dihydroquinazoline-2-CarboxamideIC5010000.0 [1]
(R)-3-[[[(S)-2-Phenyl-1-(N-methylcarbamoyl)ethyl]amino]carbonyl]-8-phenoxyoctanehydroximic acidIC5026.0 [1]
(R)-3-[[[(S)-2-Phenyl-1-(N-methylcarbamoyl)ethyl]amino]carbonyl]-8-phenoxyoctanehydroximic acidKi26.0 [1]
(2R)-2-[[(2S)-1-[[(2S)-1-Anilino-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-4-phenylbutan-2-yl]amino]propanoic acidKi760.0 [1], 770.0 [2]
2-((4-Phenoxyphenylsulfonyl)methyl)thiiraneKi206000.0 [1]
(2S,3R)-N-Hydroxy-N'-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]-3-(2-methylpropyl)-2-prop-2-enylbutanediamideIC502.2 [1], 10.0 [2]
ApratastatIC5033.0 [1], 145.0 [2]
CID 6914621IC5030000.0 [1]
CID 6914621Ki30000.0 [1]
CID 10370504IC5051000.0 [1]
Mmp inhibitor IIIC5024.0 [1]
Mmp inhibitor IIKi24.0 [1]
4-[(4-But-2-ynoxyphenyl)sulfonylmethyl]-N-hydroxy-1-propan-2-ylsulfonylpiperidine-4-carboxamideIC508780.0 [1]
N-Hydroxy-4-(4-phenylsulfanylphenyl)sulfonyl-1-prop-2-ynylpiperidine-4-carboxamideIC505000.0 [1], 8660.0 [2]
(6S,7R,10S)-6-N-Hydroxy-10-N-methyl-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-6,10-dicarboxamideIC503.0 [1]
(6S,7R,10S)-6-N-Hydroxy-10-N-methyl-7-(2-methylpropyl)-8-oxo-2-oxa-9-azabicyclo[10.2.2]hexadeca-1(14),12,15-triene-6,10-dicarboxamideKi1.2 [1]
(2S,3R)-2-(Cyclopropylmethylamino)-N-hydroxy-N'-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-3-[(3-hydroxyphenyl)methyl]butanediamideIC5010000.0 [1]
(2S,3R)-2-(Cyclopropylmethylamino)-N-hydroxy-N'-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-3-[(3-hydroxyphenyl)methyl]butanediamideKi33160.0 [1]
(2S)-2-[[4-(4-Methoxyphenyl)phenyl]sulfonylamino]-3-methylbutanoic acidIC501500.0 [1], 8710.0 [2]
(2R,3R)-1-[4-[(2-Chloro-4-fluorophenyl)methoxy]phenyl]sulfonyl-N,3-dihydroxy-3-methylpiperidine-2-carboxamideIC50200.0 [1], 310.0 [2]
Benzyl 6-Benzyl-5,7-Dioxo-6,7-Dihydro-5h-[1,3]thiazolo[3,2-C]pyrimidine-2-CarboxylateIC5030000.0 [1], 100000.0 [2]
(8S,11R,12S)-12-N-Hydroxy-8-N-(2-morpholin-4-yl-2-oxoethyl)-2,10-dioxo-11-[[4-[2-(trifluoromethyl)phenyl]phenyl]methyl]-1-oxa-3,9-diazacyclopentadecane-8,12-dicarboxamideKi2000.0 [1]
N-Hydroxy-2-[(4-methoxy-benzenesulfonyl)-(4-nitro-benzyl)-amino]-acetamideIC5028.18 [1]
N-Hydroxy-2-[(4-methoxy-benzenesulfonyl)-(4-nitro-benzyl)-amino]-acetamideKi28.0 [1]
N-Hydroxy-2-[(4-nitro-benzyl)-(nonafluorobutane-1-sulfonyl)-amino]-acetamideIC5061.66 [1]
N-Hydroxy-2-[(4-nitro-benzyl)-(nonafluorobutane-1-sulfonyl)-amino]-acetamideKi62.0 [1]
(3R)-2-[Ethoxy-(4-methoxyphenyl)phosphoryl]-N-hydroxy-3,4-dihydro-1H-isoquinoline-3-carboxamideKi4.59 [1]
Tert-butyl (6S,9R,10S)-10-(hydroxycarbamoyl)-6-(methylcarbamoyl)-9-(2-methylpropyl)-8-oxo-1,7-diazacyclotridecane-1-carboxylateKi1.0 [1]
(6S,7S)-N-Hydroxy-6-[(4-phenylpiperazin-1-yl)carbonyl]-5-azaspiro[2.5]octane-7-carboxamideIC505000.0 [1]
2-[Methyl(4-methoxyphenylsulfonyl)amino]-3-methyl-5-bromobenzohydroximic acidIC50114.0 [1]
N-Hydroxy-2-[2-methylpropyl-(4-phenylphenyl)sulfonylamino]acetamideIC504100.0 [1], 4800.0 [2]
2-[Methyl[4-(2-propynyloxy)phenylsulfonyl]amino]-3-methyl-5-bromobenzohydroximic acidIC5052.0 [1], 113.0 [2]
3-{2-Cyclohexyl-1-[2-(4-sulfamoyl-phenyl)-ethylcarbamoyl]-ethylcarbamoyl}-6-p-tolyl-hexanoic acidKi47800.0 [1], 47863.01 [2]
3-[1-(2-Carboxy-ethylcarbamoyl)-2-cyclohexyl-ethylcarbamoyl]-6-p-tolyl-hexanoic acidKi100000.0 [1]
3-[2-Cyclohexyl-1-(2-methoxycarbonyl-ethylcarbamoyl)-ethylcarbamoyl]-6-p-tolyl-hexanoic acidKi41400.0 [1], 41686.94 [2]
(RS)-3-(2-Cyclohexyl-1-phenethylcarbamoyl-ethylcarbamoyl)-6-phenyl-hexanoic acidKi20892.96 [1], 21100.0 [2]
3-[2-Cyclohexyl-1-(4-morpholin-4-yl-butylcarbamoyl)-ethylcarbamoyl]-6-p-tolyl-hexanoic acidKi55000.0 [1], 100000.0 [2]
(3R)-3-[[(2S)-3-Cyclohexyl-1-oxo-1-[2-(4-sulfamoylphenyl)ethylamino]propan-2-yl]carbamoyl]-6-(4-methoxyphenyl)hexanoic acidKi10000.0 [1], 100000.0 [2]
(3R)-6-(4-Chlorophenyl)-3-[[(2S)-3-cyclohexyl-1-oxo-1-[2-(4-sulfamoylphenyl)ethylamino]propan-2-yl]carbamoyl]hexanoic acidKi54954.09 [1], 55000.0 [2]
3-(1-Carbamoyl-2-cyclohexyl-ethylcarbamoyl)-6-phenyl-hexanoic acidKi100000.0 [1]
3-[2-Cyclohexyl-1-(2-methoxycarbonyl-ethylcarbamoyl)-ethylcarbamoyl]-6-phenyl-hexanoic acidKi57543.99 [1], 57800.0 [2]
3-[1-(3-Carbamoyl-propylcarbamoyl)-2-cyclohexyl-ethylcarbamoyl]-6-phenyl-hexanoic acidKi28183.83 [1], 28400.0 [2]
3-{2-Cyclohexyl-1-[2-(4-sulfamoyl-phenyl)-ethylcarbamoyl]-ethylcarbamoyl}-6-phenyl-hexanoic acidKi39810.72 [1], 40200.0 [2]
(S)-3-((S)-2-Cyclohexyl-1-phenethylcarbamoyl-ethylcarbamoyl)-6-phenyl-hexanoic acidKi19952.62 [1], 20000.0 [2]
(R)-3-[[[(S)-2-Phenyl-1-(N-methylcarbamoyl)ethyl]amino]carbonyl]-7-(benzyloxy)heptanehydroximic acidKi1450.0 [1], 1500.0 [2]
(R)-3-[[[(S)-2-Phenyl-1-(N-methylcarbamoyl)ethyl]amino]carbonyl]-7-phenoxyheptanehydroximic acidKi8.0 [1]
3-(2-Cyclohexyl-1-phenethylcarbamoyl-ethylcarbamoyl)-6-p-tolyl-hexanoic acidKi21877.62 [1], 22100.0 [2]
(2R)-N-[(2S)-3-Cyclohexyl-1-oxo-1-(2-phenylethylamino)propan-2-yl]-N'-hydroxy-2-(3-phenylpropyl)butanediamideKi203.0 [1]
(2R)-4-(1,3-Dioxobenzo[f]isoindol-2-yl)-2-[[(2S)-4-methyl-1-[[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopentan-2-yl]amino]butanoic acidIC5020.0 [1], 34.0 [2]
(2R)-4-(1,3-Dioxobenzo[f]isoindol-2-yl)-2-[[(2S)-4-methyl-1-[[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopentan-2-yl]amino]butanoic acidKi5.0 [1]
TanomastatIC505000.0 [1]
TanomastatKi5000.0 [1]
N-Isobutyl-N-[4-methoxyphenylsulfonyl]glycyl hydroxamic acidIC50300.0 [1]
N-Isobutyl-N-[4-methoxyphenylsulfonyl]glycyl hydroxamic acidKi174.0 [1]
(3S)-4-{[4-(But-2-ynyloxy)phenyl]sulfonyl}-N-hydroxy-2,2-dimethylthiomorpholine-3-carboxamideIC506.6 [1], 7.0 [2]
Unii-Q56UE7E40YIC505000.0 [1]
(R)-5-(6-Cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-1,2,4-oxadiazole-3-carboxamideIC5010000.0 [1]
N-[(1S)-1-[(4S)-2,2-Dimethyl-1,3-dioxolan-4-yl]-2-[4-[4-(trifluoromethoxy)phenoxy]phenyl]sulfonylethyl]-N-hydroxyformamideIC508900.0 [1], 50000.0 [2]
2-[Benzyl-(4-methoxyphenyl)sulfonylamino]-N-hydroxy-3-methylbutanamideIC5042.66 [1]
2-[Benzyl-(4-methoxyphenyl)sulfonylamino]-N-hydroxy-3-methylbutanamideKi43.0 [1]
(R)-N-Hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamideIC50147.0 [1], 490.0 [2]
Methyl rosmarinateIC5014700.0 [1], 14740.0 [2]
cis-2-Aminocyclohexylcarbamoylphosphonic acidIC50100000.0 [1]
N-[(2S)-1-(4,4-Dimethyl-2,5-dioxoimidazolidin-1-yl)-3-[4-[4-(trifluoromethoxy)phenyl]phenoxy]propan-2-yl]-N-hydroxyformamideIC504600.0 [1]
2-[Benzyl-(4-methoxyphenyl)sulfonylamino]-N-hydroxyacetamideIC5060.26 [1]
2-[Benzyl-(4-methoxyphenyl)sulfonylamino]-N-hydroxyacetamideKi60.0 [1]
N-Hydroxy-1-(2-methoxyethyl)-4-[4-[4-(trifluoromethoxy)phenoxy]phenyl]sulfonylpiperidine-4-carboxamideIC5010000.0 [1]
N-Hydroxy-1-(2-methoxyethyl)-4-[4-[4-(trifluoromethoxy)phenoxy]phenyl]sulfonylpiperidine-4-carboxamideKi10000.0 [1]
3-[(4'-Cyanobiphenyl-4-Yl)oxy]-N-HydroxypropanamideIC5010.0 [1], 3300.0 [2]
4-{[1-Methyl-2,4-Dioxo-6-(3-Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2h)-Yl]methyl}benzoic AcidIC5030000.0 [1]
(2R)-N'-Hydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2-[(3-hydroxyphenyl)methyl]butanediamideKi30953.0 [1]
(3R,4R)-N-Hydroxy-4-[[4-[[2-(trifluoromethyl)benzimidazol-1-yl]methyl]benzoyl]amino]oxane-3-carboxamideKi4948.0 [1], 10000.0 [2]
Items per page: 1 - 10 of 100
⟨⟩

References

This online tool may be cited as follows

MLA

"Quest Database™ Matrix metalloproteinase-1 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 9 May. 2024, https://www.aatbio.com/data-sets/matrix-metalloproteinase-1-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024, May 9). Quest Database™ Matrix metalloproteinase-1 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/matrix-metalloproteinase-1-inhibitors-ic50-ki.
BibTeXEndNoteRefMan
Location: Home / Datasets / Matrix metalloproteinase-1 Inhibitors (IC50, Ki)
AboutPrivacyTerms of UseTerms of SalesDistributors
Copyright © 2024 AAT Bioquest, Inc. All Rights Reserved.